With the stock market uncertain and rising theft, these are three healthcare stocks to sell in the event of a market downturn. More
Articles
ESPR Stock Earnings: Esperion Therapeutics Beats EPS, Beats Revenue for Q1 2024
ESPR stock results show that Esperion Therapeutics beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. More
HSIC Stock Earnings: Henry Schein Beats EPS, Misses Revenue for Q1 2024
HSIC stock results show that Henry Schein beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. More
GEO Stock Earnings: GEO Group Misses EPS, Beats Revenue for Q1 2024
GEO stock results show that GEO Group missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024. More
CELH Stock Earnings: Celsius Holdings Beats EPS, Misses Revenue for Q1 2024
CELH stock results show that Celsius Holdings beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. More
ATKR Stock Earnings: Atkore Beats EPS, Misses Revenue for Q2 2024
ATKR stock results show that Atkore beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024. More
